Efficacy of tablet glucocorticoids depending on their starting dose in patients with type 2 amiodarone-induced thyrotoxicosis: a prospective randomized study
Background: Glucocorticoids are the first-line pharmacotherapy for amiodarone-induced destructive thyroiditis. Despite the availability of clinical guidelines, there is no unified approach to patient management (indications for prescription, starting dose, duration of therapy and withdrawal algorith...
Main Authors: | Alexandra S. Ermolaeva, Valentin V. Fadeev |
---|---|
Format: | Article |
Sprog: | Russian |
Udgivet: |
MONIKI
2024-10-01
|
Serier: | Alʹmanah Kliničeskoj Mediciny |
Fag: | |
Online adgang: | https://almclinmed.ru/jour/article/viewFile/17290/1669 |
Lignende værker
-
Amiodarone-induced thyrotoxicosis type 2: predictors and treatment options
af: A. S. Ermolaeva, et al.
Udgivet: (2019-05-01) -
Thyroidectomy in patients with amiodarone-induced thyrotoxicosis
af: U. A. Tsoy, et al.
Udgivet: (2021-08-01) -
Amiodarone-induced thyrotoxicosis: state of the art
af: Elena A. Lebedeva, et al.
Udgivet: (2017-10-01) -
Differential diagnosis of amiodarone-induced thyrotoxicosis in a patient with atrial fibrillation and agranulocytosis on the background of thyrostatic therapy. Case report
af: Kristina Yu. Zherebchikova, et al.
Udgivet: (2024-05-01) -
Acute myopathy secondary to amiodarone-induced thyrotoxicosis
af: Dave Duggan, et al.
Udgivet: (2021-12-01)